STOK stock will be listed today, IPOing at $18, market cap of ~$550mm.  They have a drug for treating Dravet Syndrome which is in in Phase 3 trials.
 
Show notes:
~greetings and salutations~
$STOK: Stroke Therapeutics
$ADBE: Adobe
$AXTA: Axalta Coating
~intermission~
$IRWD: Ironwood Pharma
$MLNT: Melinta
~fin~

STOK stock will be listed today, IPOing at $18, market cap of ~$550mm. They have a drug for treating Dravet Syndrome which is in in Phase 3 trials. Show notes: ~greetings and salutations~ $STOK: Stroke Therapeutics $ADBE: Adobe $AXTA: Axalta Coating ~intermission~ $IRWD: Ironwood Pharma $MLNT: Melinta ~fin~

STOK stock will be listed today, IPOing at $18, market cap of ~$550mm. &nbsp;They have a drug for treating Dravet Syndrome which is in in Phase 3 trials.
 
Show notes:
~greetings and salutations~
$STOK: Stroke Therapeutics
$ADBE: Adobe
$AXTA: Axalta Coating
~intermission~
$IRWD: Ironwood Pharma
$MLNT: Melinta
~fin~

Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure

A daily stock market show for active investors and traders. We cover a deep dive into individual stock news that will most likely move stocks for that day.

Share Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure

Sign up to save your podcasts

Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure

Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure